Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
Clinical trial NCT06207370 · RECRUITING
Trial details
- NCT number
- NCT06207370
- Sponsor
- 60 Degrees Pharmaceuticals LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-17
- Primary completion
- 2027-03-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.